VitaLeech Bioscience N.V. developed a recombinant enzyme for the treatment of periodontitis, a form of inflammation of the gum that may result in the loss of teeth.
Periodonditis is a widespread disorder among 40+ year-olds. Oral care products with a proven efficacy against periodontitis do not exist yet.
Portfolio: MedSciences Capital B.V.
Current product development stage: programme has stopped.